SECsense Logo

Biogen Inc. 8-K Report: Key Insights on February 12, 2025 Filing

$BIIB
Form 8-K
Filed on: 2025-02-12
Source
Biogen Inc. 8-K Report: Key Insights on February 12, 2025 Filing

Based on the provided XML section of the financial report, here are the key insights:

  1. Entity Information:
  • Company Name: Biogen Inc.
  • CIK (Central Index Key): 0000875045
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 0-19311
  • IRS Employer Identification Number: 33-0112644
  • Headquarters Address: 225 Binney Street, Cambridge, MA 02142
  • Contact Number: 617-679-2000
  1. Report Type:
  • Filing Type: 8-K (Report of unscheduled material events or corporate changes)
  1. Filing Date:
  • Date of Filing: February 12, 2025
  1. Stock Information:
  • Common Stock Par Value: $0.0005
  • Stock Ticker: BIIB
  • Exchange: NASDAQ
  1. Period of Report:
  • Start Date: February 12, 2025
  • End Date: February 12, 2025

Summary:

This section indicates that Biogen Inc. filed an 8-K report on February 12, 2025, regarding an unspecified material event. The report confirms key corporate identifiers, including its SEC and IRS numbers, as well as its stock information. The information is relevant for stakeholders tracking corporate governance, financial performance, and any significant developments that could impact the company's stock.